Effect of combined therapy of mesenchymal stem cells with GLP-1 receptor agonist, exenatide, on early-onset nephropathy induced in diabetic rats
Heba A. Habib, Gehan H. Heeba, Mohamed Mansour Khalifa
Topics & Concepts
ExenatideMedicineDiabetic nephropathyMesenchymal stem cellInternal medicineEndocrinologyDiabetes mellitusRenal functionType 2 diabetesPathologyPancreatic function and diabetesMetabolism, Diabetes, and CancerMesenchymal stem cell research